Biomat USA

About Us

Our mission is to help save lives. We make plasma medicines that treat people with chronic, rare and sometimes very serious diseases. If you know someone who receives infusions of these medicines, there’s a chance they come from Grifols.

Our medicines are used in emergency situations as well as to treat bleeding disorders like hemophilia, a respiratory condition known as Alpha 1 Antitrypsin Deficiency, primary immunodeficiency diseases and many other disorders. A plasma medicine is often the only treatment option for these patients.

We can only produce lifesaving medicines with your help. Plasma cannot be manufactured in a lab, so plasma medicines depend on people’s compassion and generosity. To help meet the growing need for plasma, Grifols has established the largest network of plasma donation centers in the U.S. and globally.

There are more than 400 plasma donation centers spanning the U.S., Canada, Europe and Egypt. Grifols’ industry-leading quality and safety standards, beginning at our donor centers and continuing throughout the manufacturing process, ensure patients receive the highest quality medicines.

Our rigorous standards are why healthcare professionals trust Grifols products and services across the U.S. and more than 110 other countries. All of us at Grifols – we’re more than 23,000 strong – clock in at work every day singularly focused on helping millions of patients around the world lead healthier and more productive lives.

Since our founding in 1909, we have worked to advance plasma science. Our history includes breakthroughs such as the development of the plasmapheresis (pronounced PLAZ-mah fair-EE-sis) technique. This procedure revolutionized the safe and efficient collection of plasma. Today our milestone innovation is still the gold standard worldwide for obtaining plasma, the starting material needed for our medicines.